VivoSeq
Other

Experimental

3

Pipeline Programs↗

9

Active Trials↗

10

Companies Involved↗

Experimental is an early-stage landscape with 3 programs across 10 companies. The most active players are Bristol-Myers Squibb, GSK, Boehringer Ingelheim.

Intelligence

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

PreclinicalMedicines for Malaria Venture logo

Medicines for Malaria Venture

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 13

Active Inhaled Cannabis

Hannah Harris

Placebo Cannabidiol

Hannah Harris

Placebo Inhaled Cannabis

Hannah Harris

Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

98

clinical trials

Completed72 · 73%
Unknown status7 · 7%
Terminated6 · 6%
Not yet recruiting3 · 3%
Withdrawn3 · 3%
Recruiting3 · 3%
Other4 · 4%

Clinical Trials

Trial Activity

98 trials

Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
Recruiting·—·Phase 1·NCT01940757·35 enrolled
Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants
Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT06180759·18 enrolled
The Effects of Repeated CBD Administration on Cannabis Abuse Liability and Analgesia: A Human Laboratory Study
Recruiting·—·Phase 1·NCT07434895·23 enrolled
The Role of the LC-NA System in Experimental Sleep Fragmentation
Not yet recruiting·—·Phase 1·NCT07167316·42 enrolled
Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium
Not yet recruiting·AAzienda Sanitaria Locale di Asti·N/A·NCT07455773·80 enrolled
Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Drinking
Not yet recruiting·UUniversity of Florida·Preclinical·NCT06670794·160 enrolled
Modeling Tobacco Regulatory Impacts in Appalachia Using the Experimental Tobacco Marketplace
Enrolling by invitation·—·N/A·NCT06234722·473 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation·National Cancer Institute (NCI)·N/A·NCT00068003·7,000 enrolled
SMART-program：Dual Sensory-Stimulation for Relieving Feeding Difficulty and Triggering Oral Intake Among People With Dementia
Enrolling by invitation·NNational Cheng Kung University·Preclinical·NCT07678515·30 enrolled
Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00321061·60 enrolled
Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.
Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT00795938·18 enrolled
Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT02223000·9 enrolled
A Study of Experimental Medication BMS-986036 Given to Healthy Participants
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT03445208·30 enrolled
Phase 1 Safety Study of Two Experimental HIV Vaccines
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00479999·35 enrolled
An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants
Completed·Bristol-Myers Squibb logoBristol-Myers Squibb·Phase 1·NCT03634969·50 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)